Die Präsentation wird geladen. Bitte warten

Die Präsentation wird geladen. Bitte warten

Lancing: What is the future? Lutz Heinemann Profil Institute for Clinical Research, San Diego, US Profil Institut für Stoffwechselforschung, Neuss Science.

Ähnliche Präsentationen


Präsentation zum Thema: "Lancing: What is the future? Lutz Heinemann Profil Institute for Clinical Research, San Diego, US Profil Institut für Stoffwechselforschung, Neuss Science."—  Präsentation transkript:

1 Lancing: What is the future? Lutz Heinemann Profil Institute for Clinical Research, San Diego, US Profil Institut für Stoffwechselforschung, Neuss Science & Co, Düsseldorf

2 A Glance into the Crystal Ball (you dont always see what you want to see)

3 Conflict of interest Profil perform clinical-experimental and clinical studies in cooperation with numerous companies Scientific Advisory Boards / Advisory Panels Consultant No stock of any companies!

4 View of patients with diabetes (1) One of the things I use a lot is a lancing device. Dont we all? Yes, yes we do, but I dont think many people give them that much thought. (visited June 12, 2010)

5 View of patients with diabetes (2) Many discussion about this topic in blogs of patients, pros and cons of the different devices Patients are most often not involved in the selection of the lancing device! Selection of the lancet devices handed over to them by chance or simply the one that comes along with the BG meter Replacing a lancet at a time is consuming and laborious

6 Landscape of diabetes management and the position of lancing

7 Content of presentation Why finger-pricking? Which size of blood drop do we need? Why do we prick finger tips? What induces pain? What do patients do in reality? How can we reduce the pain? Which lancing devices are the best and why? What is needed? What is the future?

8 Content of presentation Why finger-pricking? Which size of blood drop do we need? Why do we prick finger tips? What induces pain? What do patients do in reality? How can we reduce the pain? Which lancing devices are the best and why? What is needed? What is the future?

9 Why finger pricking? Intensified insulin therapy requires SMBG in capillary blood samples collected at the finger tips Finger pricking makes the SMBG an annoying procedure (more pain than insulin injection) Major reason (besides the costs) why patients do not to measure their BG frequently Small number of publications about lancets and modern lancing devices (more recently) Again an aspect that is highly relevant for patients that is ignored by academic research Considerable know-how has accumulated inside the respective companies

10 Content of presentation Why finger-pricking? Which size of blood drop do we need? Why do we prick finger tips? What induces pain? What do patients do in reality? How can we reduce the pain? Which lancing devices are the best and why? What is needed? What is the future?

11 Hönes J, Müller P, Surridge N: The technology behind glucose meters: test strips. Diabetes Technol Ther 2008;10(Suppl 1):S10–S26. Which size of blood drop do we need?

12 Sample volume: μL This is a large drop of blood This was necessary for blood glucose determination using the glucose meters in 1974.

13 Blood volume at the fingertip and alternative glucose test-site (forearm) 10 µl <3 µl FingertipForearm

14 Which size of blood drop do we need? It is not only the size of the blood drop needed for the measurement per se that is relevant Blood drops must be of appropriate size to allow patients to see it and to guide the tip of the test strip to it Blood drop must have a certain size to allow sucking up of the required volume with certainty Reproducible generation of a small blood drop (<1.0 µL) is practically difficult Realistically 2-4 µL are needed

15 Content of presentation Why finger-pricking? Which size of blood drop do we need? Why do we prick finger tips? What induces pain? What do patients do in reality? How can we reduce the pain? Which lancing devices are the best and why? What is needed? What is the future?

16 Why do we prick finger tips? High blood flow at the finger tips Allows generation of blood drops with the first attempt (= high success rate) Patients hate to prick again!

17 Laser Doppler-Flux in upper dermal layers (<2 mm) - Representative examples - Forearm 91 PU Finger 638 PU 542 PU Abdomen Ball of Thumb 96 PU 1404 [PU] Koschinsky, Jungheim

18 Content of presentation Why finger-pricking? Which size of blood drop do we need? Why do we prick finger tips? What induces pain? What do patients do in reality? How can we reduce the pain? Which lancing devices are the best and why? What is needed? What is the future?

19 Klicken Sie, um die Formate des Gliederungstextes zu bearbeiten Zweite Gliederungsebene Dritte Gliederungsebene Vierte Gliederungsebe ne Fünfte Gliederungs ebene Sechste Gliederungs ebene Siebente Gliederungs ebene Achte Gliederungs ebene Neunte GliederungsebeneTextma sterformat bearbeiten Zweite Ebene Dritte Ebene Vierte Ebene Fünfte Ebene What induces pain? Invention of modern lancets allow penetration of skin with reduced pain - Special sharpening - Polished surface with coating - Soft insertion without friction into the skin Is this sufficient? More physiologic factors are of relevance Work of Fruhstorfer and colleagues in the early 1990: - insertion depths - vibrations

20 Top Layer of Skin (Epidermis) Strateum Corneum Capillary Loops Nerve Sensors

21 Insertion depth of the needle

22 Pelikan Technology (2) Insertion and retraction of the needle

23 Klicken Sie, um die Formate des Gliederungstextes zu bearbeiten Zweite Gliederungsebene Dritte Gliederungsebene Vierte Gliederungsebe ne Fünfte Gliederungs ebene Sechste Gliederungs ebene Siebente Gliederungs ebene Achte Gliederungs ebene Neunte GliederungsebeneTextma sterformat bearbeiten Zweite Ebene Dritte Ebene Vierte Ebene Fünfte Ebene What induces pain? A number of factors are of relevance and must be carefully controlled to reduce pain: Depth of penetration Speed of penetration Shape of the needle Surface Movement Skin fixation All this must be achieved to allow lancing without pain One other factor!

24 Klicken Sie, um die Formate des Gliederungstextes zu bearbeiten Zweite Gliederungsebene Dritte Gliederungsebene Vierte Gliederungsebe ne Fünfte Gliederungse bene Sechste Gliederungse bene Siebente Gliederungse bene Achte Gliederungse bene Neunte GliederungsebeneTextmas terformat bearbeiten Zweite Ebene Dritte Ebene Vierte Ebene Fünfte Ebene Klicken Sie, um die Formate des Gliederungstextes zu bearbeiten Zweite Gliederungsebene Dritte Gliederungsebene Vierte Gliederungsebe ne Fünfte Gliederungse bene Sechste Gliederungse bene Siebente Gliederungse bene Achte Gliederungse bene Neunte GliederungsebeneTextmas terformat bearbeiten Zweite Ebene Dritte Ebene Vierte Ebene Fünfte Ebene Native and used lancet after one skin penetration

25 Klicken Sie, um die Formate des Gliederungstextes zu bearbeiten Zweite Gliederungsebene Dritte Gliederungsebene Vierte Gliederungsebe ne Fünfte Gliederungse bene Sechste Gliederungse bene Siebente Gliederungse bene Achte Gliederungse bene Neunte GliederungsebeneTextmas terformat bearbeiten Zweite Ebene Dritte Ebene Vierte Ebene Fünfte Ebene Klicken Sie, um die Formate des Gliederungstextes zu bearbeiten Zweite Gliederungsebene Dritte Gliederungsebene Vierte Gliederungsebe ne Fünfte Gliederungse bene Sechste Gliederungse bene Siebente Gliederungse bene Achte Gliederungse bene Neunte GliederungsebeneTextmas terformat bearbeiten Zweite Ebene Dritte Ebene Vierte Ebene Fünfte Ebene What induces pain? Repeated usage

26 Content of presentation Why finger-pricking? Which size of blood drop do we need? Why do we prick finger tips? What induces pain? What do patients do in reality? How can we reduce the pain? Which lancing devices are the best and why? What is needed? What is the future?

27 What do patients do in reality? Survey in Germany: 2000 people with diabetes were randomly chosen to be a representative sample of patients performing SMBG according to age, sex and type of treatment Questionnaire sent out: – Nearly 1000 people responded Performed by Marktforschungsinstitut Ipsos, Hamburg Sponsor: Roche Diagnostics, Mannheim, Germany Koschinsky T. Blood glucose self-monitoring report 2006 reveals deficits in knowledge and action. Diabetes, Stoffwechsel und Herz 16: , 2007

28 10% Total (n = 966) 19% 25% 22% 5% 16% once 2-4 times 5-7 times 8-10 times times 14 times and more Nutzungshäufigkeit einer Lanzette What do patients do in reality?

29 Content of presentation Why finger-pricking? Which size of blood drop do we need? Why do we prick finger tips? What induces pain? What do patients do in reality? How can we reduce the pain? = AST Which lancing devices are the best and why? What is needed? What is the future?

30 Alternate sites testing for blood glucose measurement Capillary blood sampling from sites other than the fingertips Advantage: - less densely innervated = reduced pain perception Disadvantages: - Poor correlation in glycemia between finger tips and AST when glycemia changes rapidly - pain (?) - blood stains in the skin/clothes - perform this procedure in public

31 Content of presentation Why finger-pricking? Which size of blood drop do we need? Why do we prick finger tips? What induces pain? What do patients do in reality? How can we reduce the pain? = Laser Which lancing devices are the best and why? What is needed? What is the future?

32 Lasette, Cell Robotics ISO tech Laser Doctor® Send a laser beam to the skin to burn a little hole into the very upper layers of the skin only, Advantage: - no stimulation of pain receptors Disadvantages: - devices is bulky and expensive - side effects: a certain bang, a little cloud of smoke, some smell and not generating a sufficient amount of blood each time

33 Content of presentation Why finger-pricking? Which size of blood drop do we need? Why do we prick finger tips? What induces pain? What do patients do in reality? How can we reduce the pain? = Laser Which lancing devices are the best and why? What is needed? What is the future?

34 Content of presentation Why finger-pricking? Which size of blood drop do we need? Why do we prick finger tips? What induces pain? What do patients do in reality? How can we reduce the pain? = Laser Which lancing devices are the best and why? = electronic approach What is needed? What is the future?

35 Key factors determining precision of penetration depth

36 Perfect control of needle movement/depth of insertion Advantages: - no pain! - new approach / new ideas Disadvantages: - Company is not active anymore - devices was expensive ($200) - no publications Same happened with the Renew Lancing system (not electronic) Electronic approach: Pelikan Technologies

37 Content of presentation Why finger-pricking? Which size of blood drop do we need? Why do we prick finger tips? What induces pain? What do patients do in reality? How can we reduce the pain? = Laser Which lancing devices are the best and why? = mechanical approaches What is needed? What is the future?

38 Mechanical approaches: Complex technique is required (Roche Dig.)

39 Mechanical approaches: Complex technique is required (LifeScan)

40 Successful reduction in pain Adapted from: Jendrike et al. Diabetologie u. Stoffwechsel 2010

41 Combination of all steps involved in SMBG in one device Kocher S, Tshiananga JK, Koubek R: Comparison of lancing devices for self- monitoring of blood glucose regarding lancing pain. J Diabetes Sci Technol 3: , 2009

42 Igls 2008 Klicken Sie, um die Formate des Gliederungstexte s zu bearbeiten Zweite Gliederungseb ene Dritte Gliederungs ebene Vierte Gliederun gsebene Fünfte Glieder ungseb ene Sechste Glieder ungseb ene Siebent e Glieder ungseb ene Achte Glieder ungseb ene Neunte Gliederungseben eTextmasterform at bearbeiten Zweite Ebene Dritte Ebene Vierte Ebene » Fünfte Ebene Results In all 62 study participants >1µl blood was obtained in 83.9% with one of the three lowest penetration depths

43 Igls 2008 Results – Pain Sensation 60% of the successful fingerpricks were without any pain (descriptors nothing or touch) 38% of patients described a light prick 2% (one patient) a prick no participant characterized strong pain

44 Content of presentation Why finger-pricking? Which size of blood drop do we need? Why do we prick finger tips? What induces pain? What do patients do in reality? How can we reduce the pain? = Laser Which lancing devices are the best and why? What is needed? What is the future?

45 Klicken Sie, um die Formate des Gliederungstextes zu bearbeiten Zweite Gliederungsebe ne Dritte Gliederungse bene Vierte Gliederung sebene Fünfte Gliederu ngseben e Sechste Gliederu ngseben e Siebent e Gliederu ngseben e Achte Gliederu ngseben e Neunte Gliederungsebene Click to edit Master text styles Second level Third level Fourth level Fifth level What is needed? More interest of the academic world for this topic Specific attention on lancing in the diabetes training courses for patients

46 Klicken Sie, um die Formate des Gliederungstextes zu bearbeiten Zweite Gliederungsebe ne Dritte Gliederungse bene Vierte Gliederung sebene Fünfte Gliederu ngseben e Sechste Gliederu ngseben e Siebent e Gliederu ngseben e Achte Gliederu ngseben e Neunte Gliederungsebene Click to edit Master text styles Second level Third level Fourth level Fifth level What is needed? Appropriate clinical trials (devices per se and long- term studies) Head-to-head comparison Outcome pain but also sufficient size of blood drop Single-blind, appropriate set-up, training of technicians Independent! Most studies were performed by a manufacturer of the device, the outcome is clear… Endpoints? Register all studies at Clintrial.gov, publish them!

47 Content of presentation Why finger-pricking? Which size of blood drop do we need? Why do we prick finger tips? What induces pain? What do patients do in reality? How can we reduce the pain? = Laser Which lancing devices are the best and why? What is needed? What is the future?

48 CGM without need for calibration and recalibration Combination of all SMBG steps in one device Further improvement of e.g. the shape of the needle Performance of a long-term clinical trial that demonstrates that a reduced pain associated with lancing is worth the investment to gain reimbursement Else?

49 Combination of all steps involved in SMBG in one device (first attempts)

50 mendor discreet Portable all-in-one Blood glucose meters Integrated lancing device 25 strips in one cartridge No need for carry case Easy to use and discreet

51 Klicken Sie, um die Formate des Gliederungstextes zu bearbeiten Zweite Gliederungsebe ne Dritte Gliederungse bene Vierte Gliederung sebene Fünfte Gliederu ngseben e Sechste Gliederu ngseben e Siebent e Gliederu ngseben e Achte Gliederu ngseben e Neunte Gliederungsebene Click to edit Master text styles Second level Third level Fourth level Fifth level There is a lot to gain in lancing! Great options for improvement taking all our knowledge into account It is tricky to improve the currently already available systems within cost and size boundaries Aim is: Low cost high performance system in the interest of the patients with diabetes What is the future? My personal view!

52 Klicken Sie, um die Formate des Gliederungstextes zu bearbeiten Zweite Gliederungsebene Dritte Gliederungseben e Vierte Gliederungse bene Fünfte Gliederun gsebene Sechste Gliederun gsebene Siebente Gliederun gsebene Achte Gliederun gsebene Neunte GliederungsebeneText masterformat bearbeiten Zweite Ebene Dritte Ebene Vierte Ebene Fünfte Ebene Klicken Sie, um die Formate des Gliederungstextes zu bearbeiten Zweite Gliederungsebene Dritte Gliederungseben e Vierte Gliederungse bene Fünfte Gliederun gsebene Sechste Gliederun gsebene Siebente Gliederun gsebene Achte Gliederun gsebene Neunte GliederungsebeneText masterformat bearbeiten Zweite Ebene Dritte Ebene Vierte Ebene Fünfte Ebene Klicken Sie, um die Formate des Gliederungstextes zu bearbeiten Zweite Gliederungsebene Dritte Gliederungseben e Vierte Gliederungse bene Fünfte Gliederun gsebene Sechste Gliederun gsebene Siebente Gliederun gsebene Achte Gliederun gsebene Neunte GliederungsebeneText masterformat bearbeiten Zweite Ebene Dritte Ebene Vierte Ebene Fünfte Ebene Thank you very much for your attention! Lancing: Quo Vadis? by Lutz Heinemann, Ph.D.1,2 Dirk Boecker, M.D., Ph.D.3 1Profil Institut für Stoffwechselforschung GmbH. Neuss, Germany 2Profil Institute for Clinical Research Inc, San Diego, CA, US 3Toto Consulting, LLC, Palo Alto, CA, US Journal of Diabetes Science and Technology (June issue) 2011


Herunterladen ppt "Lancing: What is the future? Lutz Heinemann Profil Institute for Clinical Research, San Diego, US Profil Institut für Stoffwechselforschung, Neuss Science."

Ähnliche Präsentationen


Google-Anzeigen